Skip to main content

Site notifications

LENTOCILIN S 1200 benzathine benzylpenicillin 1,200,000 IU/4 mL powder and solvent for suspension for injection (Portugal)

Section 19A approved medicine
LENTOCILIN S 1200 benzathine benzylpenicillin 1,200,000 IU/4 mL powder and solvent for suspension for injection (Portugal)
Section 19A approval holder
​​Neon Healthcare Pty Ltd​ ABN ​57 670 586 526​
Phone
02 7255 8455
Approved until
Status
Current
Medicines in short supply/unavailable
BICILLIN L-A benzathine benzylpenicillin tetrahydrate 1,200,000 Units / 2.3 mL suspension for injection pre-filled syringe with needle - ARTG 147169
Indication(s)

Intramuscular benzathine benzylpenicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. Therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response.

The following infections will usually respond to adequate dosage of intramuscular benzathine benzylpenicillin:

  • Streptococcal infections (Group A - without bacteraemia). Mild-to-moderate infections of the upper respiratory tract (e.g., pharyngitis).
  • Venereal infections - Syphilis, yaws, bejel and pinta.

Medical conditions in which benzathine benzylpenicillin therapy is indicated as prophylaxis:

  • Rheumatic fever - Prophylaxis with benzathine benzylpenicillin has proven effective in preventing recurrence of this condition. It has also been used as follow-up prophylactic therapy for rheumatic heart disease.
Images
Picture of LENTOCILIN S 1200 benzathine benzylpenicillin 1200000 IU/4 mL powder and solvent for suspension for injection - carton
Picture of LENTOCILIN S 1200 benzathine benzylpenicillin 1200000 IU/4 mL powder and solvent for suspension for injection - vial